StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) income statement

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$5.80−0.32 (-5.23%)

Close on Nov 20, 2026Market cap $349.71MP/E –Yield –

Eupraxia Pharmaceuticals Inc. financial ratios

See a number that looks wrong?